OFT to rule on key pathology mergers as another project collapses

By James Illman and Sarah Calkin2013-10-16T10:19:00

Fresh evidence has emerged of the impact competition probes are having on plans to reconfigure services after Office of Fair Trading investigations were cited as barriers to two major pathology reorganisations.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here